The n0n ransomware group listed Vir Biotechnology, Inc. on its data leak site on 2026-11-16. Country: US Sector: Healthcare Claim as published on the leak site: biopharmaceutical (chronic hepatitis infections) · United States | Hepatitis D and hepatitis B testing and treatment claims for a US biopharmaceutical company's franchise: 113,235,341 patient level rows covering 7,144,993 distinct patients, with ages, birth years, payer details and provider identities; Prescription claims for the company's hepatitis D product with patient identifiers, prescriber NPI numbers and payer details | [NOT PAID — EXPOSED]